Trial intelligence / Profile preview

ACCESS-AMI

NCT06854523Not yet recruiting

Start
Apr 2025
Primary completion
Dec 2026
Countries
1
01

Overview

Randomised, open-label trial in acute myocardial infarction (AMI) (2 arms). Primary endpoints: Index of Plaque Attenuation at 12 months and Perivascular Fat Attenuation Index at 12 months. Planned start Apr 2025; status: not yet recruiting.

02

Conditions

acute myocardial infarction (AMI)

Beyond the preview

Go deeper on NCT06854523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06854523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call